Skip to content

PHARMANATUUR

Active
Private limited companyfounded 20223 yrs activeDaalstraat 34, 1790 Affligem, BelgiumKBO/BCE: BE 0791.769.428
Summary

The computed 12-month bankruptcy probability of PHARMANATUUR is 5.5% (elevated). The 2023 annual accounts show negative equity (-€25,815) and a net result of -€35,815. Its solvency ranks better than 12% of 24620 sector peers (fiscal year 2023). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Bankruptcy probability: Elevated
Axes, FY 2023
Profitability0
Solvency0
Growth-
Track record79
Bankruptcy probability, 12 months
5.5% Elevated
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2023
Solvency, return and age of the figures
Solvency
-50.1%
Return on assets
-69.5%
Age of the figures
33 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Filed after the deadline
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 19-08-2024, 19 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2023
19 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its 2023 accounts 19 days after the deadline; the sector median for financial year 2023 is on the deadline day, and 48% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

PHARMANATUUR was incorporated on 3 October 2022 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2023.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2023

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2023, micro schema

Equity
-€25,815
Total assets
€51,561
Net result
-€35,815
Working capital
-€29,169

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €51,561
Fixed assets €12,485
Current assets €39,075
Key figures and ratios
2023 value
EBITDA
-€31,817
Cash flow
-€33,948
Solvency
-50.1%
Current ratio
0.57
Quick ratio
0.11
Debt to equity
-3.00
ROA
-69.5%
Interest coverage
-14.91
Debt
€77,376
Debt ≤ 1 year
€68,244
Debt > 1 year
€9,131
Staff costs
€5,579
Annual accounts
Filed annual accounts As filed with the NBB · 2023 · 41 lines
Balance sheet Code2023
Assets
Total assets20/58€51,561
Fixed assets21/28€12,485
Tangible fixed assets22/27€10,640
Plant, machinery and equipment23€9,871
Furniture and vehicles24€769
Financial fixed assets28€1,845
Current assets29/58€39,075
Stocks and contracts in progress3€31,229
Stocks30/36€31,229
Amounts receivable within one year40/41€2,883
Trade receivables40€2,767
Other amounts receivable41€116
Cash at bank and in hand54/58€4,339
Deferred charges and accrued income490/1€624
Equity and liabilities
Total equity and liabilities10/49€51,561
Equity10/15-€25,815
Contributions10/11€10,000
Profit (loss) carried forward14-€35,815
Amounts payable17/49€77,376
Amounts payable after more than one year17€9,131
Financial debts170/4€9,131
Amounts payable within one year42/48€68,244
Current portion of amounts payable after more than one year42€17,226
Trade debts44€5,175
Suppliers440/4€5,175
Taxes, remuneration and social security45€641
Remuneration and social security454/9€641
Other amounts payable47/48€45,202
Income statement Code2023
Remuneration, social security and pensions62€5,579
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,867
Other operating charges640/8€554
Gross operating margin9900-€25,685
Operating profit (loss)9901-€33,684
Financial income75/76B€3
Recurring financial income75€3
Financial charges65/66B€2,134
Recurring financial charges65€2,134
Profit (loss) for the period before taxes9903-€35,815
Profit (loss) for the period9904-€35,815
Profit (loss) for the period to be appropriated9905-€35,815
Appropriation of the result
Profit (loss) to be appropriated9906-€35,815

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2023
Remuneration, social security and pensions62€5,579
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,867
Other operating charges640/8€554
Gross operating margin9900-€25,685
Operating profit (loss)9901-€33,684
Financial income75/76B€3
Recurring financial income75€3
Financial charges65/66B€2,134
Recurring financial charges65€2,134
Profit (loss) for the period before taxes9903-€35,815
Profit (loss) for the period9904-€35,815
Profit (loss) for the period to be appropriated9905-€35,815
Line2023
Assets
Total assets20/58€51,561
Fixed assets21/28€12,485
Tangible fixed assets22/27€10,640
Plant, machinery and equipment23€9,871
Furniture and vehicles24€769
Financial fixed assets28€1,845
Current assets29/58€39,075
Stocks and contracts in progress3€31,229
Stocks30/36€31,229
Amounts receivable within one year40/41€2,883
Trade receivables40€2,767
Other amounts receivable41€116
Cash at bank and in hand54/58€4,339
Deferred charges and accrued income490/1€624
Equity and liabilities
Total equity and liabilities10/49€51,561
Equity10/15-€25,815
Contributions10/11€10,000
Profit (loss) carried forward14-€35,815
Amounts payable17/49€77,376
Amounts payable after more than one year17€9,131
Financial debts170/4€9,131
Amounts payable within one year42/48€68,244
Current portion of amounts payable after more than one year42€17,226
Trade debts44€5,175
Suppliers440/4€5,175
Taxes, remuneration and social security45€641
Remuneration and social security454/9€641
Other amounts payable47/48€45,202
Line2023
Profit (loss) for the period9904-€35,815
+ Depreciation and write-downs630€1,867
Operating cash flow (approximation)-€33,948

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2024
19-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 19 days late
NBB filing
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Affligem · 1 establishment unit since 2022
seat establishment The establishment unit on the map
Ground area
1,153 m²
Building footprint
255 m²
Volume, LiDAR
1,163 m³
2 parcels, Flanders · tallest building 8.3 m, ±2 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
Parijsstraat 24, 9310 Aalst
Retail sale of pharmaceutical products
since 20222.336.284.293
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
41039B0319/00M000 Flanders 1,039 m² 1 · 175 m² 8.3 m · 1 fl.
23085A0458/00N000 Flanders 114 m² 1 · 80 m² 6.3 m · 2 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded03-10-2022
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47750Retail sale of cosmetics and toilet articles
82990Other business support services
Contact
E-mail pharmanatuure@gmail.comAalst
Phone 0483495716Aalst
E-invoicing
Reachable via Peppol
Peppol ID 0208:0791769428
Also 9925:BE0791769428
Registered 24-11-2023

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.